Carerx Corporation · TSX:CRRX

Carerx — Investor Presentation (March 2025)

16 slides from Carerx's investor presentation, Mar 20, 2025

  1. Slide 1: Investor Presentation March 2025

    INVESTOR PRESENTATION March 2025 TSX: CRRX

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs

  3. Slide 3: Canada's leading provider of specialty pharmacy services to seniors housing communities

    Canada’s leading provider of specialty pharmacy services to seniors housing communities Enhancing the health of seniors with complex medication needs with high-touch, same-day delivery of specially packaged medications 3 3

  4. Slide 4: Canadian Market

    Canadian Market 1 in 5 Typical Seniors in Adults 65+ consume Canadians long-term care take ~40% are aged 4 to 12 of prescription drugs & medications daily ~25% 65 or older of OTC drugs Source: Statistics Canada 4 4 An aging population is driving unprecedented demand for medications and care services

  5. Slide 5: Operational and Financial Highlights

    Operational and Financial Highlights Nationwide ~88,000 ~1,450 Footprint Beds serviced Seniors housing communities served 26 5+ Fulfillment Year average contract CareRx centres term with our largest Tripled customers Bed count ~88,000 since 2020 $92.2M $7.6M 8.2% 2024 Q4 2024 Q4 2024 Q4 2024 Revenue

  6. Slide 6: Comprehensive Services Offering

    Comprehensive Services Offering Servicing Seniors Service Seniors Living Pharmacists Distribution Facilities Living Facilities Onsite geriatric-certified clinical A leading distributor of medical Automated dispensing cabinets pharmacists + pharmacist-led supplies and continence and medication incide

  7. Slide 7: Investment Highlights

    Investment Highlights 1 2 3 4 Differentiated Contracted Increasing Infrastructure & Strategy Recurring Revenue Demand Technology Largest pure-play 5+ year contract length Increasing seniors National platform with pharmacy focused on with largest customers population and best-in-class technology long

  8. Slide 8: Differentiated Strategy

    Differentiated Strategy Retail Facility move-in consultation and specialized geriatric visits ✓  Deprescribing and routine medication reviews for safety & health ✓ ? 24/7 emergency medications and availability ✓  Free caregiver education and daily delivery ✓ ? Reduced errors with specialized packa

  9. Slide 9: Contracted Recurring Revenue

    Contracted Recurring Revenue • 5+ year contract length with largest customers funded by government payors • Capitated fee (fee/bed/month or fee-for-service) model for medications dispensed and clinical services Government Insurance • Payments billed directly to government and insurance • Non-covered

  10. Slide 10: Increasing Demand

    Increasing Demand Currently >500,000 1,025,000 CareRx congregate care beds 89,000 beds in Canada1 18% + Canada’s over 65 population is projected to grow by 2.7 million Current market has The Ontario over the next 5 years ~500,000 beds1 government has pledged to build Spending on senior care expected

  11. Slide 11: Infrastructure & Technology

    Infrastructure & Technology PacMed BD Rowa Key Technologies Supported by LTC Pharmacies Dose • Unit dose “pouch” packaged medications (PacMed and BD Rowa Dose) • eMAR software • Automated dispensing cabinets (ADCs) • Digital prescribing technologies (CPOE) • Medication incident management systems Te

  12. Slide 12: Growth Strategy

    Growth Strategy Organic Bed Wins • Broadening scope of products and services (e.g. Revicare, BOOMR., etc.) • Leverage scale & capabilities to provide superior pharmacy services offering • Increased focus on expansion to other congregate care settings • LTC occupancy increasing post-Covid Existing Pa

  13. Slide 13: Financial Performance

    Financial Performance Revenue Adj. EBITDA Operating Cash Flow $32.3 $38.0 $30.3 $381.7 $370.7 $28.7 $366.7 $22.9 $27.4 $262.6 $22.3 $7.3 FY '21 FY '22 FY '23 FY '24 FY '21 FY '22 FY '23 FY '24 FY '21 FY '22 FY '23 FY '24 Note: All figures in millions. 13 13 Organic growth and acquisitions driving ca

  14. Slide 14: Experienced Leadership Team

    Experienced Leadership Team Puneet Khanna President & Chief Executive Officer Travis Featherstone Former Chief Commercial Officer, COO and SVP, Corporate Development of SVP, Western Operations & System Integration CareRx; former CEO of MED e-care Healthcare Solutions; former VP, Strategy & New Busin

  15. Slide 15: Capitalization

    Capitalization At Dec. 31, 2024 Ownership Common Stock Ownership Shares Outstanding 62.2M Share Price1 C$2.55 Yorkville Asset Management 16,301,305 26.3% Market Cap C$158.5M Directors & Officers 6,600,348 10.7% Polar Asset Management 10,095,107 16.3% Cash $9.1M Debt $45.3M Other 29,998,714 46.8% Ter

  16. Slide 16: oe Carekx , ‘ ‘| rerx.ca

    i, oe Carekx , ‘ ‘| rerx.ca PV dlc) THE FUTURE OF SENIOR CARE ’

CareRx — Investor Presentation (March 2025) on 6ix